CXCR2 and cancer: Similarly to IL-6, the CXCR2 (C-X-C motif chemokine receptor 2)/IL-8 axis induced by KRAS was shown to be crucial for promoting phenotype alterations of CAFs (cancer-associated fibroblasts) and increased secretion of pro-tumoral cytokines that eventually promoted the development of PDAC [30].